Picard Medical is trading 5.6% up at $4.44 in after-hours trading, with the rebound apparently linked to stronger broad-market sentiment.
- The rebound follows a sharp regular-session decline on September 21, 2026.
- No verified company-specific announcement, earnings release, or analyst action dated September 21 was identified.
- The latest documented financial release was its August 19 second-quarter report; its NYSE American compliance-plan announcement predates September 21.